An Exploratory Clinical Trial of Autologous Humanized Anti-cluster of Differentiation Antigen 19/20(CD19/CD20) Dual Specific CAR-T Cells Injection

NCT04486872 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

BIOLOGICAL: Autologous humanized anti-CD19 and anti-CD20 dual specific CAR-T Cells

Sponsor

First Affiliated Hospital of Zhejiang University